HealthNotableReported
5.9
Brazil's Anvisa bans unregistered tirzepatide/retatrutide pens
Poder360·BR·about 21 hours ago
HealthReportedLow
2.1
Brazil's Anvisa lifts suspension of Unilever factory in São Paulo after corrections
Brazil's health regulator Anvisa lifted the suspension of a Unilever factory in São Paulo after a reinspection confirmed that irregularities found in August were corrected. The suspension had not triggered a product recall. This is a routine regulatory resolution with no market-moving implications.
Score Breakdown
Mosaic Score2.1
Model confidence0.9
Significance0.1
Source credibility0.4
Related signals
8 foundMarketsNotableReportedDeveloping
5.7
IPSConsumo urges Cade to restrict American-Azul deal, cites United-Gol links
Valor Econômico·BR · US·about 11 hours ago
MarketsNotableReported
5.7
Keeta resumes expansion into 21 new cities after exclusivity ruling
InfoMoney·BR·about 13 hours ago
MarketsReported
2.1
B3 Extends IMC Share Price Adjustment Deadline to 2027
Valor Econômico·BR·about 9 hours ago
HealthReported
2.1
Anvisa suspends Janssen batch over possible glass contamination in Imaavy
Poder360·BR·about 19 hours ago
HealthReported
2.1
Brazil's Anvisa approves Ordexa, lisdexamfetamine-based ADHD drug
Poder360·BR·2 days ago
EnergyUnknown
2.1
Brazil's Aneel approves three energy auctions for existing plants, set for Nov 13
Valor Econômico·BR·about 17 hours ago
PoliticsHighReportedAccelerating
9.7
Bolsonaro's Son Leads Brazil Presidential Vote Despite Corruption Probes
Le Monde·BR·about 22 hours ago